1. Home
  2. Stock quotes
  3. Alexion Pharmaceuticals, Inc.
  4. Financial Statements
  5. Balance Sheet
  6. Deferred Revenue
Alexion Pharmaceuticals, Inc. logo
Alexion Pharmaceuticals, Inc. ALXN
$ 182.5 0.0%
mail-toReport an Error

Alexion Pharmaceuticals, Inc. Deferred Revenue 2011-2024 | ALXN

Annual Deferred Revenue Alexion Pharmaceuticals, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 15.9 M 37 M 20.5 M 58.8 M 53.8 M 31.3 M 18.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
58.8 M 15.9 M 33.7 M